about
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's diseaseThe Progress of Induced Pluripotent Stem Cells as Models of Parkinson's DiseaseHeterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implicationsCopper phenotype in Alzheimer's disease: dissecting the pathwayLipid pathway alterations in Parkinson's disease primary visual cortexCumulative exposure to lead and cognition in persons with Parkinson's diseaseA behavioral genetics approach to understanding D1 receptor involvement in phasic dopamine signaling.A three dimensional anatomical view of oscillatory resting-state activity and functional connectivity in Parkinson's disease related dementia: An MEG study using atlas-based beamformingDementia and neuroimaging.The spectrum of cognitive disorders in Parkinson's disease: a data-driven approach.BAG2 structure, function and involvement in disease.Parkinson's disease subtypes show a specific link between dopaminergic and glucose metabolism in the striatum.Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional studyThe neurobiological basis of cognitive impairment in Parkinson's disease.Subregional 6-[18F]fluoro-ʟ-m-tyrosine uptake in the striatum in Parkinson's disease.Defining at-risk populations for Parkinson's disease: lessons from ongoing studies.Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.RNAi medicine for the brain: progresses and challenges.Cognition in movement disorders: where can we hope to be in ten years?Influence of ERβ selective agonism during the neonatal period on the sexual differentiation of the rat hypothalamic-pituitary-gonadal (HPG) axis.Clinico-pathological correlations of the most common neurodegenerative dementias.Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease.Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson's Disease Brains Are Differentially Generated in Mammalian Cell ModelsThe role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's diseaseBasal ganglia-cortical interactions in Parkinsonian patients.Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease(123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study.The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regionsGrey matter changes in cognitively impaired Parkinson's disease patients.Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease.Problems associated with fluid biomarkers for Parkinson's disease.Parkinson's disease dementia and potential therapeutic strategies.Energy matters: mitochondrial proteomics for biomedicine.Milestones in Parkinson's disease--clinical and pathologic features.Neuropathology underlying clinical variability in patients with synucleinopathies.Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.
P2860
Q24324577-A586C075-DC0E-429F-A05D-822C1C51ED0FQ26765894-939426FB-4BA4-4711-BEA3-A34F0B0803E6Q27013695-DD6A1D99-E7E8-4F8B-842D-2DD2FB6C73E2Q28294380-9BA34462-5268-4F9E-B597-34CE1E1759A1Q28386548-87682DCB-DD5E-460D-99F7-483FC81F1ACBQ28394876-31DBBF9C-CD5A-485A-BD84-D918F7D11EE9Q30474975-A2E1DCE5-598D-4CFE-B23C-7E1BD8E2BA44Q30545574-55F10B0A-AE91-435B-8600-555785AEF1F8Q30581757-F03C03E5-F0A9-4FFC-A67F-03C519A413EFQ30593620-EC8DA0FC-A2F2-438F-8466-BCA86CAF0C17Q33634944-61E5BE10-EB20-4E3F-B940-8A2788686FDEQ33644318-DD6098D5-3586-4BC0-84A6-687CF9ACB45AQ33672820-CEF2D24F-556D-47B5-9000-E4E820BE4576Q33724698-96C9863B-6143-43D6-82EC-9A9E56DB966DQ33853332-9ABF8391-FFE7-449D-A1B2-79B854046DAFQ34234632-834EF4CB-B1FE-467B-8A88-26364B3A26DBQ34553777-710306A6-9947-46F4-B475-5438B608D714Q34673305-9D822049-1480-4EC7-BA98-E3D8AAD8539AQ34982838-BA10C520-2229-415A-A59D-C47D07E80C07Q35211553-432BCCBD-9A29-469B-B60C-4EAC959E1A76Q35797949-015AB65D-E28E-4617-BCF5-8145F4EDB99AQ35923461-614B99A0-80BB-47B2-AB41-702CD49FBEFCQ36060128-D15295AD-646F-4A15-9A12-9FDE8BC0EAD7Q36139079-45A413F6-1D8F-4806-8341-089C4C7C9F81Q36325701-8B36C187-2515-457B-B39B-6E5A3BC024A0Q36612089-2C9D3203-33D2-44B6-B0E7-6D15DBB7FC20Q36718213-95976584-15F5-40FD-91A2-8F6564EA1D46Q36810006-784DB71E-639F-4E3B-A2FA-E7135A68677EQ36818525-B49D5EE2-AB06-4085-8356-FCB52875B73CQ37499581-ECC4BDA7-4CA8-43E1-A37B-5D98345AAE61Q37715886-69D6BCA5-FAA5-4638-84F5-0A12EF3A42B8Q37800100-ECA06941-6BA0-4547-BC3D-AE452DE91D01Q37825631-59618A65-2282-4ACC-8C38-1578184FEE33Q37829412-E698F652-F144-4C21-A6C2-246F3A9F82B9Q37882587-33D12A5D-B2D0-4020-943D-DF6FB8D7DC28Q37896515-269C2812-3F1C-4C36-9998-4F6FF1101DE3Q38003065-FC1443F1-B086-4CFD-A2F6-C1026F5D909AQ38014888-C28F1A58-307F-4241-B1D8-6ACA2E9CEFD8Q38115298-501852CE-B0DC-40D8-8D5F-B530E07FA632Q38603309-17D349A0-25FB-4F2E-AF7A-911F8D8D2635
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The progression of pathology in Parkinson's disease.
@en
The progression of pathology in Parkinson's disease.
@nl
type
label
The progression of pathology in Parkinson's disease.
@en
The progression of pathology in Parkinson's disease.
@nl
prefLabel
The progression of pathology in Parkinson's disease.
@en
The progression of pathology in Parkinson's disease.
@nl
P2860
P1476
The progression of pathology in Parkinson's disease.
@en
P2093
Heather McCann
P2860
P304
P356
10.1111/J.1749-6632.2009.05118.X
P407
P577
2010-01-01T00:00:00Z